AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primary for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Astrazeneca is the 7th largest ethical multinational pharmaceutical company in the Philippines. It is home to 270 employees nationwide who understand that their mission is not just to provide high quality innovative medicines, but to offer physicians the opportunity to constantly improve patient care.

We invested US$3.03 billion in 2020 in research and development of new medicines to meet patient needs. AstraZeneca Philippines takes part in global research with 27 dedicated people working on 23 ongoing clinical trials, involving more than 300 patients, in more than 30 sites all over the Philippines.

Primary Contact

AstraZeneca Pharmaceuticals (Phils.), Inc.
16th Floor, Inoza Tower,
40th Street, Bonifacio Global City,
Taguig 1634
Philippines

(+63 2) 8777-8700

ph-info@vbj4.com

The-Philippines

If you are taking any of AstraZeneca’s medicines and you experience an adverse event defined as a

Development of an undesirable condition or deterioration of pre-existing medical condition following or during exposure to a pharmaceutical product, whether or not causally related to the product, would like to report a product quality issue or would like to request information about AstraZeneca’s medicines,

You may report/request via the CHAMPion Form: http://contactazmedical.vbj4.com/

Patient Safety & Medical Information

Phone:  (+63 2) 8 777 8700
Email (Patient Safety) : PatientSafety.PH@vbj4.com
Email (Medical Information): medinfo.ph@vbj4.com